| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,106 |
2,039 |
$96K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,264 |
1,191 |
$64K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
580 |
514 |
$20K |
| 80053 |
Comprehensive metabolic panel |
1,705 |
1,541 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
374 |
356 |
$11K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
374 |
356 |
$11K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
562 |
555 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
380 |
337 |
$10K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
93 |
93 |
$10K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
505 |
468 |
$9K |
| 0240U |
|
81 |
80 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
419 |
388 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,666 |
1,495 |
$7K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
90 |
31 |
$6K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
135 |
133 |
$6K |
| 87660 |
|
276 |
264 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
449 |
405 |
$5K |
| 87480 |
|
276 |
264 |
$4K |
| 87510 |
|
276 |
264 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
97 |
90 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
42 |
41 |
$1K |
| 81001 |
|
637 |
591 |
$1K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
83 |
78 |
$1K |
| 59025 |
Fetal non-stress test |
39 |
24 |
$1K |
| 84484 |
|
121 |
101 |
$1K |
| 84703 |
|
145 |
136 |
$977.87 |
| 85730 |
|
157 |
141 |
$557.38 |
| 85610 |
|
158 |
142 |
$482.50 |
| 83690 |
|
109 |
96 |
$480.27 |
| 87653 |
|
12 |
12 |
$432.28 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$406.96 |
| 85027 |
|
72 |
67 |
$382.36 |
| 84443 |
Thyroid stimulating hormone (TSH) |
39 |
38 |
$353.50 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
14 |
12 |
$271.36 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
30 |
25 |
$240.79 |
| 88142 |
|
12 |
12 |
$170.01 |
| 87899 |
|
14 |
12 |
$160.61 |
| 80061 |
Lipid panel |
26 |
25 |
$123.30 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
148 |
136 |
$114.41 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
94 |
77 |
$110.45 |
| 86850 |
|
14 |
12 |
$93.79 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
102 |
90 |
$92.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
74 |
50 |
$91.79 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
72 |
66 |
$71.92 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
29 |
27 |
$59.60 |
| 86140 |
|
13 |
13 |
$58.53 |
| 86592 |
|
12 |
12 |
$48.13 |
| 86901 |
|
15 |
12 |
$36.90 |
| 36415 |
Collection of venous blood by venipuncture |
2,761 |
2,453 |
$35.51 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
374 |
363 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
203 |
160 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
30 |
28 |
$0.00 |